Stay updated on Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Sign up to get notified when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.

Latest updates to the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page
- Check3 days agoChange DetectedAdded related disease term familial multiple polyposis syndrome and an external resource link to the Genetic and Rare Diseases Information Center for additional context.SummaryDifference0.2%

- Check10 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded revision: v3.4.3; removed revision: v3.4.2.SummaryDifference0.1%

- Check52 days agoChange DetectedAdded a new revision note: Revision: v3.4.2; the funding-status notice and the previous revision (v3.4.1) were removed.SummaryDifference0.5%

- Check59 days agoChange DetectedAdded a government funding lapse notice and updated the site to revision v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check67 days agoChange DetectedAdded a glossary toggle and a new 'Last Update Submitted that Met QC Criteria' field in Study Record Dates, and updated the footer to show 'No FEAR Act Data' and 'Revision: v3.4.0' (replacing 'No FEAR Act data' and 'Revision: v3.3.4'). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.